Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2025 / July / LiP-MS Reveals Misfolded Proteins Linked to Memory Loss
Proteomics Business & Entrepreneurship Proteomics Translational Science Omics

LiP-MS Reveals Misfolded Proteins Linked to Memory Loss

Using structural proteomics, researchers uncover widespread protein misfolding linked to cognitive decline

By Henry Thomas 07/30/2025 2 min read

Share

The widely studied amyloid and tau aggregates linked to Alzheimer’s disease may represent only a fraction of the protein misfolding that occurs in aging brains, according to a new study. Using limited proteolysis mass spectrometry (LiP-MS), researchers at Johns Hopkins University identified over 200 proteins with altered structures in the brains of cognitively impaired rats – proteins that do not form visible plaques, yet may contribute to memory loss and neurological decline.

Credit: Brain image sourced from Pixabay.com

The study, published in Science Advances, analyzed hippocampal tissue from 2-year-old rats, a model of advanced age. While some animals performed poorly in memory and problem-solving tasks, others remained cognitively intact. The researchers used LiP-MS to compare the CA1 subfield of the hippocampus between these groups, probing more than 2,700 proteins for conformational differences. They identified 214 “cognition-associated structural changes” (CASCs) – proteins that were significantly misfolded in impaired rats but not in their high-performing peers. These proteins spanned a range of functional categories, including translation, synaptic transmission, and protein degradation pathways.

“Amyloids are just the tip of the iceberg,” said senior author Stephen Fried, assistant professor of chemistry at Johns Hopkins, in a recent press release. “We're seeing hundreds of proteins misfolding in ways that don't clump together into an amyloid and yet still seem to impact how the brain functions.”

To further investigate these changes, the team subjected the misfolded proteins to chemical denaturation and refolding assays. CASCs were significantly more likely to be nonrefoldable, suggesting that their native structures had been lost irreversibly in aged, cognitively impaired brains.

Unlike conventional proteomics approaches, which focus primarily on protein abundance, the team’s LiP-MS method enabled them to detect subtle structural alterations across thousands of proteins. By comparing protein conformations in cognitively impaired and unimpaired aged rats, they were able to pinpoint the structural changes linked specifically to memory loss, rather than to aging alone.

“We think there are a lot of proteins that can be misfolded, not form amyloids, and still be problematic,” said Fried. “That suggests these proteins have ways of escaping the cell’s surveillance system.”

The team now plans to visualize CASCs at higher resolution to better understand the molecular deformities and their impact on cellular function. “Understanding what’s physically going on in the brain could lead to better treatments and preventive measures,” Fried added.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Henry Thomas

Deputy Editor of The Analytical Scientist

More Articles by Henry Thomas

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Proteomics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

Found in Translation
Proteomics
Found in Translation

December 16, 2024

1 min read

Cryo-EM addresses a key question in gene expression: how ribosomes initiate translation

Keeping Up with the Power List: Part 1
Proteomics
Keeping Up with the Power List: Part 1

December 19, 2024

4 min read

What are the most exciting developments and emerging trends in analytical science today? We asked the 2024 Power List

Deep Profiles for Personalized Medicine
Proteomics
Deep Profiles for Personalized Medicine

December 19, 2024

1 min read

How small molecule enhancements revolutionize plasma proteomics

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.